Amneal Pharmaceuticals Inc (AMRX)
6.76
+0.55
(+8.86%)
USD |
NASDAQ |
May 03, 16:00
Amneal Pharmaceuticals Gross Profit Margin (Quarterly): 30.77% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.77% |
| September 30, 2023 | 37.50% |
| June 30, 2023 | 36.73% |
| March 31, 2023 | 31.96% |
| December 31, 2022 | 35.32% |
| September 30, 2022 | 35.60% |
| June 30, 2022 | 35.85% |
| March 31, 2022 | 35.08% |
| December 31, 2021 | 30.99% |
| September 30, 2021 | 37.55% |
| June 30, 2021 | 39.71% |
| March 31, 2021 | 38.85% |
| December 31, 2020 | 32.76% |
| September 30, 2020 | 25.72% |
| Date | Value |
|---|---|
| June 30, 2020 | 31.04% |
| March 31, 2020 | 36.81% |
| December 31, 2019 | 27.74% |
| September 30, 2019 | 14.39% |
| June 30, 2019 | 26.01% |
| March 31, 2019 | 18.62% |
| December 31, 2018 | 38.87% |
| September 30, 2018 | 42.00% |
| June 30, 2018 | 43.09% |
| March 31, 2018 | 52.54% |
| December 31, 2017 | 51.61% |
| September 30, 2017 | 53.00% |
| June 30, 2017 | 47.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
14.39%
Minimum
Sep 2019
39.71%
Maximum
Jun 2021
32.65%
Average
35.08%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.72% |
| Return on Assets | -2.30% |
| Return on Invested Capital | -2.94% |
| Profit Margin (Quarterly) | -15.99% |
| Operating Margin (Quarterly) | 5.55% |
| Return on Net Operating Assets | -2.42% |